A-dmDT390-bisFv(UCHT1) Fusion Protein in Combination With Ionizing Radiation for Treatment of Stage IV Melanoma
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to study A-dmDT390-bisFv(UCHT1) in combination with ionizing
irradiation for the treatment of stage IV melanoma, a disease that is essentially incurable
with median overall survival periods that range from 8-16 months.